Literature DB >> 30284473

SLX4: multitasking to maintain genome stability.

Jean-Hugues Guervilly1, Pierre Henri Gaillard1.   

Abstract

The SLX4/FANCP tumor suppressor has emerged as a key player in the maintenance of genome stability, making pivotal contributions to the repair of interstrand cross-links, homologous recombination, and in response to replication stress genome-wide as well as at specific loci such as common fragile sites and telomeres. SLX4 does so in part by acting as a scaffold that controls and coordinates the XPF-ERCC1, MUS81-EME1, and SLX1 structure-specific endonucleases in different DNA repair and recombination mechanisms. It also interacts with other important DNA repair and cell cycle control factors including MSH2, PLK1, TRF2, and TOPBP1 as well as with ubiquitin and SUMO. This review aims at providing an up-to-date and comprehensive view on the key functions that SLX4 fulfills to maintain genome stability as well as to highlight and discuss areas of uncertainty and emerging concepts.

Entities:  

Keywords:  DNA damage response; DNA repair and recombination; Fanconi anemia; Genome stability; interstrand cross-link repair; replication stress; structure-specific endonuclease; telomere maintenance

Mesh:

Substances:

Year:  2018        PMID: 30284473     DOI: 10.1080/10409238.2018.1488803

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  16 in total

Review 1.  Heterochromatin replication goes hand in hand with telomere protection.

Authors:  Aaron Mendez-Bermudez; Marie-Josèphe Giraud-Panis; Jing Ye; Eric Gilson
Journal:  Nat Struct Mol Biol       Date:  2020-03-30       Impact factor: 15.369

Review 2.  DNA damage kinase signaling: checkpoint and repair at 30 years.

Authors:  Michael Charles Lanz; Diego Dibitetto; Marcus Bustamante Smolka
Journal:  EMBO J       Date:  2019-08-08       Impact factor: 11.598

3.  The structure-specific endonuclease complex SLX4-XPF regulates Tus-Ter-induced homologous recombination.

Authors:  Rajula Elango; Arvind Panday; Francis P Lach; Nicholas A Willis; Kaitlin Nicholson; Erin E Duffey; Agata Smogorzewska; Ralph Scully
Journal:  Nat Struct Mol Biol       Date:  2022-08-08       Impact factor: 18.361

4.  SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations.

Authors:  A Takedachi; E Despras; S Scaglione; R Guérois; J H Guervilly; M Blin; S Audebert; L Camoin; Z Hasanova; M Schertzer; A Guille; D Churikov; I Callebaut; V Naim; M Chaffanet; J P Borg; F Bertucci; P Revy; D Birnbaum; A Londoño-Vallejo; P L Kannouche; P H L Gaillard
Journal:  Nat Struct Mol Biol       Date:  2020-05-11       Impact factor: 15.369

Review 5.  SENP Proteases as Potential Targets for Cancer Therapy.

Authors:  Paulina Tokarz; Katarzyna Woźniak
Journal:  Cancers (Basel)       Date:  2021-04-24       Impact factor: 6.639

6.  An advanced cell cycle tag toolbox reveals principles underlying temporal control of structure-selective nucleases.

Authors:  Julia Bittmann; Rokas Grigaitis; Lorenzo Galanti; Silas Amarell; Florian Wilfling; Joao Matos; Boris Pfander
Journal:  Elife       Date:  2020-05-01       Impact factor: 8.140

Review 7.  Structure-Specific Endonucleases and the Resolution of Chromosome Underreplication.

Authors:  Benoît Falquet; Ulrich Rass
Journal:  Genes (Basel)       Date:  2019-03-19       Impact factor: 4.096

Review 8.  Intricate SUMO-based control of the homologous recombination machinery.

Authors:  Nalini Dhingra; Xiaolan Zhao
Journal:  Genes Dev       Date:  2019-10-01       Impact factor: 11.361

9.  SLX4IP promotes RAP1 SUMOylation by PIAS1 to coordinate telomere maintenance through NF-κB and Notch signaling.

Authors:  Nathaniel J Robinson; Masaru Miyagi; Jessica A Scarborough; Jacob G Scott; Derek J Taylor; William P Schiemann
Journal:  Sci Signal       Date:  2021-06-29       Impact factor: 8.192

10.  WRNIP1 Protects Reversed DNA Replication Forks from SLX4-Dependent Nucleolytic Cleavage.

Authors:  Bartlomiej Porebski; Sebastian Wild; Sandra Kummer; Sarah Scaglione; Pierre-Henri L Gaillard; Kerstin Gari
Journal:  iScience       Date:  2019-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.